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1 Bupivacaine-induced cardiotoxicity increases in hypoxic and acidotic conditions. We have
analysed the eects of R(+)bupivacaine on hKv1.5 channels stably expressed in Ltk7 cells using the
whole-cell patch-clamp technique, at three dierent extracellular pH (pHo), 6.5, 7.4 and 10.0.
2 Acidification of the pHo from 7.4 to 6.5 decreased 4 fold the potency of R(+)bupivacaine to
block hKv1.5 channels. At pHo 10.0, the potency of the drug increased *2.5 fold.
3 Block induced by R(+)bupivacaine at pHo 6.5, 7.4 and 10.0, was voltage- and time-dependent in
a manner consistent with an open state block of hKv1.5 channels.
4 At pHo 6.5, but not at pHo 7.4 or 10.0, R(+)bupivacaine increased by 95+3 % (n=6; P50.05)
the hKv1.5 current recorded at 710 mV, likely due to a drug-induced shift of the midpoint of
activation (DV=78.5+1.4 mV; n=7).
5 R(+)bupivacaine development of block exhibited an ‘instantaneous’ component of block at the
beginning of the depolarizing pulse, which averaged 12.5+1.8% (n=5) and 4.6+1.6% (n=6), at
pHo 6.5 and 7.4, respectively, and that was not observed at pHo 10.0.
6 It is concluded that: (a) alkalinization of the pHo increases the potency of block of
R(+)bupivacaine, and (b) at pHo 6.5, R(+)bupivacaine induces an ‘agonist eect’ of hKv1.5
current when recorded at negative membrane potentials.
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Introduction
Bupivacaine is an amide type local anaesthetic widely used
in regional anaesthesia. Unfortunately, bupivacaine is a
very cardiotoxic local anaesthetic, likely due to its ability
to decrease intracardiac conduction velocity, contractile
force and sinoatrial activity (Strichartz, 1987) and to
prolong QRS and QTc intervals of the ECG in
anaesthetized dogs (Kasten & Martin, 1985; Wheeler et
al., 1988) and human volunteers receiving high doses of
bupivacaine (Scott et al., 1989). These cardiac eects are
the consequence of its blocking eects of Na+, Ca2+ and
several K+ channels (Kv1.5, Kv2.1, Kv1.4, Kv4.3, HERG
and KvLQT1+minK) (Clarkson & Hondeghem, 1985;
Graf et al., 1997; Lipka et al., 1998; Gonza´lez et al.,
2001). Bupivacaine presents a chiral carbon and, thus, it
can be separated into two enantiomers. It has been
reported that bupivacaine-induced cardiotoxicity is mostly
related to the eects of the R(+) enantiomer (A˚berg,
1972; Luduena et al., 1972). Bupivacaine induced block of
cardiac Na+ and hKv1.5 channels is stereoselective, being
R(+)bupivacaine 1.6- and 7 fold more potent than S(7)-
bupivacaine, respectively, whereas block of Kv2.1 and
Kv4.3 is not (Valenzuela et al., 1995a, b; Franqueza et al.,
1997; 1999). It has been postulated that the cationic form
of bupivacaine blocks hKv1.5 channels by binding to a
receptor site located at the inner mouth of the channel
involving, at least, the amino acids located at positions
T505, L508 and V512 in the S6 segment of the channel
(Valenzuela et al., 1995a; Franqueza et al., 1997).
Changes in pH like those occurring during myocardial
ischaemia, diabetic ketoacidosis, and respiratory acidosis
due to hypoventilation alter the degree of protonation
of an anaesthetic molecule and modulate both the
therapeutic and the toxic eects of the drug (Strichartz,
1987). In fact, bupivacaine-induced cardiotoxicity in-
creased in hypoxic and acidotic conditions (Rosen et
al., 1985; Nancarrow et al., 1987). Acidosis increased
the action potential duration in isolated guinea-pig
ventricular muscle and isolated dog Purkinje fibres,
causing abnormal repolarization and early afterdepolar-
izations that were suggested to be due to a decrease in
delayed rectifying potassium currents, supporting the idea
that K+ channel-mediated repolarization is impaired at
low pH (Coraboeuf et al., 1976; Fry & Poole-Wilson,
1981; Bethell et al., 1998). Recently, it has been
demonstrated that Kv1.5 channels are sensitive to low
extracellular pH changes like those occurring during
myocardial ischaemia (Steidl & Yool, 1999). Therefore,
in this study we have analysed the possible dierences
among the eects induced by R(+)bupivacaine on
hKv1.5 channels due to changes in the extracellular
pH values (pHo) (6.5 and 10.0). Preliminary results of
the present study have been published in abstract form
(Longobardo et al., 1998).
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Methods
Cell culture
Stably transfected Ltk7 cells with the gene encoding the
expression of hKv1.5 channels were cultured in DMEM
supplemented with 10% horse serum and 0.25 mg ml71 G418
(a neomycin analogue) under a 5% CO2 atmosphere as
previously described (Tamkun et al., 1991; Snyders et al.,
1993). Cultures were passaged every 3 – 5 days by use of a
brief trypsin treatment. Before experimental, subconfluent
cultures were incubated with 2 mM dexamethasone for 24 h to
induce expression of hKv1.5 channels. The cells were
removed from the dish with a rubber policeman, a procedure
that left the vast majority of the cells intact. The cell
suspension was stored at room temperature (21 – 238C) and
used within 12 h for all the experiments reported.
Electrophysiological recording
Experiments were performed in a small volume (0.5 ml) bath
mounted on the stage of an inverted microscope (Nikon
model TMS, Garden City, NY, U.S.A.) perfused continu-
ously at a flow rate of 0.5 – 1.0 ml min71. hKv1.5 currents
were recorded at room temperature (21 – 238C) using the
whole-cell voltage-clamp configuration of the patch-clamp
technique (Hamill et al., 1981) with an Axopatch 1C patch-
clamp amplifier (Axon Instruments, Foster City, CA,
U.S.A.). Currents were filtered at 2 kHz (four-pole Bessel
filter), sampled at 4 kHz, and stored on the hard disk of a
Hewlett-Packard Vectra 486 computer for subsequent
analysis. Data acquisition and command potentials were
controlled by the PCLAMP 6.0.1 software (Axon Instruments).
Micropipettes were pulled from borosilicate glass capillary
tubes (Narishige, GD-1, Tokyo, Japan) on a programmable
horizontal puller (Sutter Instrument Co., San Rafael, CA,
U.S.A.) and heat-polished with a microforge (Narishige). The
intracellular pipette filling solution contained (in mM): K-
aspartate 80, KCl 50, phosphocreatine 3, KH2 PO4 10,
MgATP 3, HEPES-K 10, EGTA 5 and was adjusted to
pH 7.25 with KOH. The bath solution contained (in mM):
NaCl 130, KCl 4, CaCl2 1.8, MgCl2 1, HEPES-Na 10, and
glucose 10, and was adjusted to pH 6.50 or 7.40 with NaOH.
In the experiments performed at extracellular pH 10.0, we
used 10 mM CAPS-Na as buer. When filled with the
intracellular solution and immersed into the bath (external
solution), the pipette tip resistance ranged between 1 and
3 MO. The micropipettes were gently lowered onto the cells
to obtain a gigaohm seal (17+3 GO) after applying suction.
After seal formation, cells were lifted from the bottom of the
perfusion bath and the membrane patch was ruptured with
brief additional suction. The capacitive transients elicited by
symmetrical 10-mV steps from 780 mV were recorded at
50 kHz (filtered at 10 kHz) for subsequent calculation of
capacitative surface area and access resistance (10.8+0.7 pF
and 4.0+0.3 MO; n=10). Thereafter, capacitance and series
resistence compensation were optimized, and 80% compensa-
tion of the eective access resistance was usually obtained,
achieving a mean value of uncompensated access resistance of
2.2+0.2 MO (n=10). Since the mean maximum current
recorded was 1.5+0.4 nA, the voltage error was under 5 mV
(2.9+0.5 mV; n=10).
Drugs
R(+)bupivacaine (a gift from Astra, So¨derta¨lje, Sweden) was
dissolved in distilled deionized water to yield stock solutions
of 1 mM from which further dilutions were made to obtain
the desired final concentration.
Pulse protocol and analysis
The holding potential was maintained at 780 mV unless
indicated otherwise. The eect of drug infusion was
monitored with test pulses to +60 mV, applied every 30 s
until steady-state was obtained. The cycle time for other pulse
protocols was 10 s. Steady-state current-voltage relationships
(IV) were obtained by averaging the current over a small
window (2 – 5 ms) at the end of 250 ms depolarizing pulses.
Between 780 and 740 mV only passive linear leak was
observed and least squares fits to these data were used for
passive leak correction. Deactivating ‘tail’ currents were
recorded either at 740 mV (experiments performed at pHo
7.4 and 10.0) or 730 mV (experiments at pHo 6.5), in order
to record deactivating tail currents at similar potentials
within the activation of the channel. The activation curve was
obtained from the tail current amplitude immediately after
the capacitive transient. Measurements were done using the
CLAMPFIT program of PCLAMP 6.0.1, Origin 5.0 (Microcal
Software, Northampton, MA, U.S.A.) and by a custom-made
analysis program.
Activation curves were fitted with a Boltzmann equation:
yÿ 1=1 expÿ Eÿ Eh=s; 1
in which s represents the slope factor, E the membrane
potential and Eh the voltage at which 50% of the channels
are open. The activation kinetics of hKv1.5 have been
described as a sigmoidal process (Snyders et al., 1993).
However, in the present study and in order to describe the
dominant time constant of this process and the eects of
drugs on it, the latter part of the current was fitted to a single
exponential, following a procedure previously described and
used for the same purpose (Snyders et al., 1993; Valenzuela et
al., 1994; Delpo´n et al., 1995). Deactivation was fitted to a
biexponential process (Rich & Snyders, 1998). Thus, this
process was fitted to an equation of the form:
y  CA1exp ÿt=t1 A2exp ÿt=t2 2
where t1, and t2 are the system time constants, A1, and A2
are the amplitudes of each component of the exponential, and
C is the baseline value. The curve-fitting procedure used a
non-linear least-squares (Gauss-Newton) algorithm; results
were displayed in linear and semilogarithmic format, together
with the dierence plot. Goodness of fit was judged by the w2
criterion and by inspection for systematic non-random trends
in the dierence plot.
Drug-channel interactions were described by one or two
binding curves. Apparent anity constant, KD, and Hill
coecient, nH, for hKv1.5 channels at pHo 7.4 were obtained
from fitting the fractional block, f, at various drug
concentrations [D] to one Hill curve:
f  1=1 KD=DnH 3
where [D] is the drug concentration. Experimental data from
hKv1.5 channels at pHo 6.5 and 10.0 were fitted to the sum
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of two Hill equations:
f  I1=1 KD1=D  I2=1 KD2=D 4
where I1 and I2 are the fractional current of each component
(I1+I2=1), KD1 and KD2 are the apparent dissociation
constants and [D] has the same meaning as above. Apparent
rate constants for binding (k) and unbinding (l) were
obtained from solving:
k D  l  tÿ1Block 5a
l=k  KD 5b
Voltage dependence of block was determined as follows:
leak-corrected current in the presence of drug was normalized
to matching control to yield the fractional block at each
voltage (f=17Idrug/Icontrol). The voltage dependence of block
was fitted to:
f  D=D  KD  exp ÿ dzFE=RT; 6
where z, F, R and T have their usual meaning, d represents
the fractional electrical distance, i.e., the fraction of the
transmembrane electrical field sensed by a single charge at the
receptor site and KD* represents the apparent dissociation
constant at the reference potential (0 mV).
Statistical methods
Results are expressed as mean+s.e.mean. Direct comparisons
between mean values in control conditions and in the
presence of drug for a single variable were performed by
paired Student’s t-test. Student’s t-test was also used to
compare two regression lines. Dierences were considered
significant if P50.05. To analyse drug or electrophysiological
eects at multiple pHo, two-way ANOVA was used
(Wallenstein et al., 1980). Throughout the manuscript, results
obtained at pHo 6.5 or 10.0 were compared to those obtained
at pHo 7.4.
Results
Effects of R(+)bupivacaine on hKv1.5 channels at pHo
6.5, 7.4 and 10.0
Figure 1A showsoriginal records elicited at pHo 6.5, 7.4 and 10.0
in the absence and in the presence of R(+)bupivacaine by
depolarizing pulses from a holding potential of 780 mV to
+60 mV in steps of 10 mV. In the absence of drug, current
rapidly activated during depolarization at +60 mV and the
dominant time constant of this process was faster at more
alkaline pHo [4.23+0.30 ms (n=20; P50.05), 2.10+0.20 ms
(n=21) and 0.76+0.04 ms (n=13; P50.05) at pHo 6.5, 7.4 and
10.0, respectively]. After reaching a maximum peak value,
hKv1.5 current slowly and partially inactivated during the
application of the depolarizing pulse. Tail currents were
recorded upon repolarization to 740 mV (pHo 7.4 and 10.0)
or 730 mV (pHo 6.5). The time course of the deactivation
process was fitted to a biexponential equation (see equation 2 in
Methods). The fast time constants (tf) averaged 21.4+1.7
(n=24; P40.05), 19.1+1.1 (n=38) and 20.5+1.4 ms (n=13;
P40.05) at pHo 6.5, 7.4 and 10.0, respectively. This component
equally contributed [36.9+3.2% (n=25; P40.05), 49.8+3.3%
(n=38) and 46.8+5.3% (n=13; P40.05) at pHo 6.5, 7.4 and
10.0, respectively] to the total deactivation of the current. The
slow time constants (ts) of this process were also similar at the
three pHo studied averaging 67.4+5.6 ms (n=24; P40.05),
60.0+6.0 ms (n=38) and 67.5+5.8 ms (n=13; P40.05), at
pHo 6.5, 7.4 and 10.0, respectively, this component contributing
to a similar extent to the total deactivation process (P40.05) at
the three pHo studied, averaging values of 63.1+3.2% (n=24),
50.2+3.3% (n=38) and 53.2+5.3% (n=13), respectively.
Table 1 shows the theoretical intracellular and extracellular
concentrations of charged and uncharged R(+)bupivacaine
after adding 5 mM R(+)bupivacaine to the external solution
at pHo 6.5, 7.4 and 10.0. Whereas at pHo 6.5, the drug will be
mostly present in its extracellular charged form; at pHo 10.0,
the opposite will occur, so that the drug will accumulate
inside the cell in its charged form (*39 mM). However, at
pHo 7.4, similar concentrations of the cationic form of
R(+)bupivacaine are expected at both sides of the cell
membrane. Figure 1A shows hKv1.5 current records
obtained in the absence and in the presence of equipotent
concentrations of R(+)bupivacaine at the three pHo studied
(20, 5 and 1 mM). It can be observed that the concentration
required to induce a 50% block is reduced as the pHo is
higher, which indicates that most of the blocking properties
of R(+)bupivacaine on hKv1.5 channels are the consequence
of its binding to a receptor site located at the inner mouth of
the ion pore of the channel. In all cases, block induced by
R(+)bupivacaine was time-dependent, inducing a fast initial
decline at the beginning of the depolarizing pulse, suggestive
of open channel block (Armstrong, 1971). Therefore, steady-
state block was measured at the end of 250 ms-depolarizing
pulses from a holding potential of 780 mV to +60 mV. At
pHo 6.5, 20 mM R(+)bupivacaine decreased hKv1.5 current
by 62+4% (n=7), at pHo 7.4, 5 mM R(+)bupivacaine
inhibited the current by 61+2% (n=5), and at pHo 10.0,
R(+)bupivacaine (1 mM) inhibited hKv1.5 current by
47+5% (n=5). Therefore, acidification of the pHo decreased
4 fold the potency of R(+)bupivacaine to block hKv1.5
channels while at pHo 10.0, the potency of the drug increased
*2.5-fold versus the potency that it exhibits at the
physiological pHo of 7.4 (Valenzuela et al., 1995a).
Figure 1B shows the activation curves of hKv1.5 channels
obtained at the three pHo tested in the absence and in the
presence of R(+)bupivacaine. Under control conditions, the
midpoint of activation (Eh) of hKv1.5 channels was shifted to
more positive membrane potentials as the pHo decreased
[+3.1+0.7 mV (n=27; P50.05), 714.2+2.1 mV (n=38)
and 723.1+1.3 mV (n=13; P50.05) at pHo 6.5, 7.4 and
10.0, respectively], without modifications in the slope factor
[5.2+0.1 mV (n=27), 4.9+0.2 mV (n=38) and 4.6+0.2 mV
(n=13) at pHo 6.5, 7.4 and 10.0]. In order to study the eects
of the pHo on hKv1.5 channels, we represented the shift of
the Eh values against the pHo (Figure 2). Considering that
DEh saturates at pHo 10.0, its value would be zero at this
pHo. As it has been previously described for other ionic
channels (Prod’hom et al., 1989; Ito et al., 1992; Yamane et
al., 1993), the Eh shift of the activation of hKv1.5 channels
induced by extracellular protons is consistent with a pKa
value of 6.4, which is very close to the pKa of histidine (6.0).
Therefore, these results suggest that titration of some
histidine within the outer pore of hKv1.5 channels might be
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involved in this eect. As it is shown in Figure 1B,
R(+)bupivacaine shifted the activation curve of hKv1.5
channels at the three pHo studied. However, this shift was
only statistically significant at pHo 6.5 (DV=78.5+1.4 mV,
n=7; P50.01), whereas at pHo 7.4 and 10.0, R(+)bupiva-
caine at 5 and 1 mM only shifted the activation curves by
74.5+0.5 (n=6; P40.05) and 73.6+0.2 mV (n=7;
P40.05), respectively. R(+)bupivacaine did not modify the
slope factor of the activation curve under any experimental
condition studied.
Figure 3 shows the concentration-response curves obtained
at pHo 6.5, 7.4 and 10.0. Although the concentration
dependence for block of hKv1.5 channels at pHo 7.4 was
adequately described by a single binding site model (Valenzuela
et al., 1995a), block induced by R(+)bupivacaine of hKv1.5
channels at pHo 6.5 or 10.0 was better fit assuming two binding
Figure 1 Eects of R(+)bupivacaine on hKv1.5 channels at dierent pHo values. Original records obtained in the absence and in
the presence of equipotent drug concentrations after applying depolarizing pulses from 780 to +60 mV in 10 mV steps of 250 ms
duration. Tail currents were recorded upon repolarization to 740 mV (pHo 7.5 and 10.0) or 730 mV (pHo 6.5). (A) Shows original
records obtained at pHo 6.5, 7.4 and 10.0 in the absence and in the presence of equipotent concentrations of R(+)bupivacaine.
R(+)bupivacaine 20, 5 and 1 mM induced a time-dependent block which yields 62+4% (n=6), 61+2% (n=5) and 47+5% (n=5)
at pHo 6.5, 7.4 and 10.0, respectively. (B) Shows the activation curves at pHo 6.5, 7.4 and 10.0 in the absence and in the presence of
equipotent R(+)bupivacaine concentrations. The midpoint of activation (Eh) was shifted to more negative potentials as the pHo
value was more alkaline. Data points represent the mean+s.e.mean of a 6 – 7 experiments. *P50.01.
Table 1 Left: concentration of neutral or charged R-bupivacaine inside and outside the cell after adding 5 mM R-bupivacaine to the
external solution at dierent pH0. Right: concentration of charged R-bupivacaine (RB
+) inside and outside the cell membrane at the
KD values obtained at pH0 6.5, 7.4 and 10.0




+]in (mM) [RB]in (mM) [RB
+]out (mM) [RB]out (mM) (mM) (mM) (mM)
6.5 0.9732 0.1225 4.8775 0.1225 19 3.5 18
7.4 6.6063 0.8317 4.1683 0.8317 4.7 4.5 5.4
10.0 39.2226 4.9378 0.0622 4.9378 1.7 38 0.0622
[RB+]in: Intracellular concentration of the cationic form of bupivacaine. [RB]in: Intracellular concentration of the neutral form of
bupivacaine. [RB+]out: Extracellular concentration of the cationic form of bupivacaine. [RB]out: Extracellular concentration of the
neutral form of bupivacaine. These values were calculated applying the Henderson-Hasselbalch equation {pH=pKa+log([RB+]/
[RB])}, where pKa represents the dissociation constant of the drug (8.1 for R(+)bupivacaine).
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sites, with the fraction of channels blocked with high anity
being*30%, similarly to that previously described for R(+)-
and S(7)-bupivacaine-block of some pore-mutant hKv1.5
channels (Franqueza et al., 1997). A nonlinear least-squares fit
of the concentration-response equation (see Methods) to the
individual data points yielded apparent KD’s of 0.066+0.040
and 19.8+2.7 mM (n=39) for R(+)bupivacaine hKv1.5 block
at pHo 6.5, and 0.027+0.007 and 1.7+0.2 mM (n=23) for
R(+)bupivacaine block at pHo 10.0.
Voltage-dependence of block of hKv1.5 channels by
R(+)bupivacaine at different pHo
Figure 4 shows the relative current obtained in the presence
of equipotent concentrations of R(+)bupivacaine at the three
pHo studied versus membrane potential. In all cases, block
induced by R(+)bupivacaine steeply increased at the
membrane potentials that coincided with the activation range
of the channel, which strongly suggests that the drug binds to
the open state of the channel. At membrane potentials
positive to +10 mV (pHo=6.5), 0 mV (pHo=7.4) and
75 mV (pHo=10.0), block still increased but with a
shallower voltage dependence. At this range of voltages the
activation curve of the channel has reached saturation and,
therefore, an increase of the degree of block cannot be
attributed to an opening of the channel. Since R(+)bupiva-
caine is a weak base (pKa=8.1) this shallow voltage
dependence of block was interpreted as the eect of the
transmembrane electrical field on the interaction between the
cationic form of the drug and its receptor in the channel,
according to a Woodhull model (Woodhull, 1973). Therefore,
Figure 2 Eects of changes in extracellular pH (pHo) on hKv1.5
channels. Considering the equation DEh=A/(1+10
(pH-pKa)); where A
represents the maximum amplitude, and assuming that Eh saturates
at pHo 10.0 (so DEh=0 at pHo=10.0), we calculated a pKa value of
6.44. This is in close agreement with the pKa value of protonation
for an histidine (6.0) and suggests that the titration of a histidine
present within the pore region of hKv1.5 channels could be
responsible for the observed proton-induced shift towards more
positive membrane potentials as the pHo is reduced.
Figure 3 Concentration-response curves for R(+)bupivacaine-in-
duced block at all the pHo studied. In this plot we represented the
R(+)bupivacaine induced block at each concentration and under
each experimental conditions. At pHo 6.5 and 10.0 the concentration-
response curves were better fit assuming a Hill equation of two
components, i.e. biphasic concentration-response curves, from which
two KD values were obtained (KD1 and KD2). Dotted lines represent
the concentration-response curves when the fit assumed a Hill
equation of one component. The concentration-response curve for
R(+)bupivacaine at pHo 7.4 (D) was taken from (Valenzuela et al.,
1995a) with permission.
Figure 4 Voltage-dependent eects of equipotent R(+)bupivacaine concentrations on hKv1.5 channels at dierent pHo values.
Relationship between the relative current (IDrug/IControl) and membrane potential at pHo 6.5, 7.4 and 10.0. At the three pHo studied,
block induced by R(+)bupivacaine steeply increased in the range of activation of the channel. At voltages positive to +10 mV (pHo
6.5), 0 mV (pHo 7.4) and 75 mV (pHo 10.0) block increased with a shallower voltage-dependence consistent with d values of
0.18+0.01 (n=14), 0.18+0.01 (n=5) and 0.16+0.01 (n=7), respectively (P40.05).
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a nonlinear curve fitting of the data to equation 6 (see
Methods) yielded the fractional electrical distance (d) values
that were 0.18+0.01 (n=14), 0.18+0.01 (n=5) and
0.16+0.01 (n=7) at pHo 6.5, 7.4 and 10.0, respectively.
Figure 5 shows original hKv1.5 current traces recorded at
very positive (+60 mV) and at the threshold for activation
(710 mV) at pHo 6.5 in the absence and in the presence of
R(+)bupivacaine. At this pHo value, R(+)bupivacaine
(20 mM) decreased hKv1.5 current recorded at +60 mV by
62+4% (n=7; P50.01), but increased the hKv1.5 current
amplitude at 710 mV, by 95+3% (n=6; P50.01). This
increase was not significant at pHo 7.4 (10+2%; n=6,
P40.05, measured at 720 mV) and at pHo 10.0 only
blocking eects could be observed (12+1%; n=5 P50.05,
measured at 730 mV). The increase of the hKv1.5 current
observed at negative membrane potentials at pHo 6.5 can be
the consequence of a drug-induced negative voltage shift of
the midpoint of the activation curve from +4.1+0.2 to
73.0+0.6 mV (n=7; P50.01). We will use the term ‘agonist
eect’ to describe the R(+)bupivacaine-induced increase of
hKv1.5 current amplitude.
Time dependence of block of hKv1.5 channels by
R(+)bupivacaine at different pHo
As it has been mentioned above, one of the most prominent
eects of R(+)bupivacaine on hKv1.5 current at any pHo
tested was the development of a fast initial decline at the
beginning of the depolarizing pulse that was superimposed on
the slow inactivation characteristic of the current (Figure
6A). The time constant of this initial decline was faster at
higher drug concentrations and, therefore, it was taken as a
good index of the time constant of the drug-channel
interaction (tBlock). Figure 6B shows the apparent rate of
block (tBlock71) versus R(+)bupivacaine concentrations at
each pHo value. The straight lines are the least squares fits to
the equation tBlock71=k6[D]+l. Slope and intercept for
fitted relations yielded the apparent association (k) and
dissociation (l) rates for R(+)bupivacaine at the three pHo
studied. At pHo 6.5 the k value for R(+)bupivacaine was 3.7
fold smaller than that obtained at pHo 7.4. However, l values
were similar at both pHo. The lower k value together with a
similar l value calculated at pHo 6.5 can explain the lower
potency of block induced by R(+)bupivacaine at pHo 6.5
compared to its potency at pHo 7.4 (KD=l/k). At pHo 10.0,
both rate constants, k and l, were modified compared to
those calculated at pHo 7.4. Thus, while the k value was 9.1
fold times faster, the l value was only 3.1 fold times faster
than values described at pHo 7.4.
R(+)bupivacaine (1 mM) did not modify the activation
time constant at pHo 10.0 [0.85+0.10 versus 0.72+0.08 ms
(n=5; P40.05)] at +60 mV. However, at pHo 6.5 and 7.4
R(+)bupivacaine (10 and 5 mM; respectively) accelerated the
activation time course of the current [2.59+0.17 ms versus
4.12+0.53 ms (n=5; P50.05) at pHo 6.5, and 1.45+0.11 ms
versus 2.00+0.11 (n=6; P50.01) at pHo 7.4]. These results
can suggest that, at pHo 6.5 and 7.4, R(+)bupivacaine may
block some state of the hKv1.5 channel previous to the open
one. In order to analyse this hypothesis we plotted the ratio
between the drug-sensitive current and that recorded under
control conditions [(IControl – IDrug)/IControl] at +60 mV versus
time of depolarization (inset of Figure 6B). As it can be
observed, at pHo 6.5, R(+)bupivacaine development of block
exhibited an ‘instantaneous’ component of block at the
beginning of the depolarizing pulse (t=0 ms), which averaged
12.5+1.8% (n=5). At pHo 7.4, a lower degree of
‘instantaneous’ block was observed (4.6+1.6%; n=6). At
these two dierent pHo, block increased further during the
application of the depolarizing pulses, indicating that
R(+)bupivacaine binds also to the open state of the channel.
At pHo 10.0 development of block began during the
depolarization without an ‘instantaneous’ component of
block (n=5; P50.05 versus results obtained at pHo 6.5).
Time dependent block of hKv1.5 channels was also
observed in the tail currents, which represent the transition
from the open to the closed state of the channel. As it has
been previously described, under control conditions, the
deactivation of hKv1.5 channels recorded at 740 mV
follows a biexponential function with fast and slow time
constants that were similar at the three pHo values studied.
If R(+)bupivacaine blocks hKv1.5 channels in the open
state, as suggested by the time- and voltage-dependence
block observed, then dissociation of R(+)bupivacaine from
the blocked channels results in an open channel (which
Figure 5 Eects of R(+)bupivacaine on hKv1.5 channels at pHo 6.5. Left panel shows original records obtained after depolarizing
the cell from 780 to +60 mV. Right panel shows the drug eects after depolarizing the cell membrane to 710 mV. Note that,
under these circumstances, the drug increased the amplitude of the hKv1.5 current by 95+3% (n=6; P50.05), whereas after strong
depolarizations (left panel), R(+)bupivacaine inhibited the hKv1.5 current.
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subsequently could close). Blocked channels are not
conducting, and the conversion to the open state should,
therefore, result initially in a rising phase of the tail current;
subsequently, the tail current should display a slower
decline because some fraction of the open channels become
blocked again, rather than closing irreversibly. Figure 7
shows the superposition of the tail currents obtained at
740 mV (pHo 7.4 and 10.0) or 730 mV (pHo 6.5) after a
250 ms depolarization to +60 mV under control conditions
and in the presence of equipotent concentrations of
R(+)bupivacaine at the three pHo. In all cases, R(+)bu-
pivacaine slowed the time course of deactivation resulting in
the ‘crossover’ phenomenon (Figure 7), which represents
another piece of evidence supporting an open channel block
mechanism (Armstrong, 1971). At the three pHo studied,
equipotent concentrations of R(+)bupivacaine (20, 5 and
1 mM) eliminated tf and therefore, the time course of
deactivation followed a monoexponential function with time
constants of 114.2+26.2 ms (n=4), 93.8+11.7 ms (n=6)
and 95.1+13.6 ms (n=5), at pHo 6.5, 7.4 and 10.0,
respectively.
Discussion
The main findings of the present study are: (1) alkalinization
of the pHo increases the potency of R(+)bupivacaine to
block hKv1.5 channels at positive membrane potentials,
consistent with the existence of an internal receptor
bupivacaine site responsible of most of the blocking eects
of R(+)bupivacaine. (2) R(+)bupivacaine at pHo 6.5 induces
an ‘agonist eect’ on hKv1.5 channels when recorded at
negative membrane potentials (physiological membrane
potentials).
Effects of pHo on hKv1.5 channels
As it has been previously described for other ion channels,
changes in pHo modify the gating of hKv1.5 channels in a
manner consistent with a surface screen of negative charges
(Busch et al., 1991; Coulter et al., 1995; Fakler et al., 1996;
Hoth et al., 1997). In fact, a decrease or an increase of the
pHo induced a positive or a negative shift in the Eh of the
activation curve, respectively. This suggests that protons
Figure 6 Time-dependent block of hKv1.5 channels induced by R(+)bupivacaine at pHo 6.5, 7.5 and 10.0. (A) Shows original
records obtained after applying a depolarizing pulse from 780 mV to +60 mV for 250 ms in duration in the absence and in the
presence of R(+)bupivacaine (20, 5 and 1 mM) at the dierent pHo values. R(+)bupivacaine induced a fast initial decline of the
current which was faster at higher drug concentrations and thus, it was considered as a good index of the time constant of block
(tBlock). (B) The inverse of tBlock was plotted versus bupivacaine concentration. For a first-order blocking scheme, a linear relation is
expected: tBlock71=k6[D]+l (see Methods section). The solid line represents the linear fit, from which the apparent binding and
unbinding rate constants were obtained. Inset: Representative traces of time course of the development of block of hKv1.5 after a
depolarizing pulse to +60 mV from a holding potential of 780 mV at pHo 6.5, 7.4 and 10.0 induced by R(+)bupivacaine at
concentrations of 10, 5 and 1 mM, respectively. The reduction of hKv1.5 current in the presence of the drug is expressed as a
proportion of the control current at any given time after the beginning of the depolarizing pulse. In the presence of
R(+)bupivacaine at all the pHo studied inhibition of the current increases exponentially during depolarization. Note that at pHo 6.5
and 7.4, R(+)bupivacaine (10 mM) induced an instantaneous block at t=0 ms.
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decrease the negative charge at the external surface of the
membrane, in the vicinity of the hKv1.5 channel gate and
thus, alter the voltage field sensed by the channel mechanism.
The activation kinetics was also modified by the pHo, being
faster as the pHo increased, indicating that changes in the
surface charges modify the kinetics of this channel, maybe
due to a modification of the channel gating. The pHo-
dependent properties of dierent inwardly rectifying potas-
sium channels and Kv1.3 channels have been attributed to
the protonation of titrable amino acids such as histidine
(Busch et al., 1991; Coulter et al., 1995; Hoth et al., 1997),
cysteine (Coulter et al., 1995) or lysine (Fakler et al., 1996).
Most of these amino acids are located near the outer part of
the pore region. Recently, it has been demonstrated that the
rat isoform of Kv1.5 channels (rKv1.5) is extremely sensitive
to pHo (Steidl & Yool, 1999). Protonation of a histidine
located at position 452 in the pore region causes channels to
accumulate in the C-type inactivated state inducing a
reduction of Kv1.5 current amplitude (Steidl & Yool, 1999).
In the present study, the observed Eh shift induced by
extracellular protons is consistent with a pKa value of 6.4,
which is very close to pKa of histidine (6.0). Since the human
isoform of Kv1.5 channels (hKv1.5) exhibits an histidine at
equivalent position to 452 in rKv1.5 channels, this amino
acid might be responsible of the changes in Eh.
R(+)bupivacaine blocks the open state of hKv1.5
channels at the three pHo studied
Block induced by R(+)bupivacaine at the three pHo studied
was voltage dependent, consistent with a d value of *0.17
when measured from the inside of the membrane (Figure 4).
Also, at the three pHo studied, R(+)bupivacaine induced a
fast initial decline of the maximum outward current upon
depolarization from 780 to +60 mV, indicative of an open
channel mechanism (Figure 6). Furthermore, R(+)bupiva-
caine slowed the deactivation process inducing a tail ‘cross-
over’ phenomenon at all pHo studied (Figure 7). All these
results are consistent with an open channel block mechanism
in which the cationic form of R(+)bupivacaine (RB+) binds
to a receptor located at the inner mouth of the ion pore of
hKv1.5 channels blocking them when they achieve their open
state (Valenzuela et al., 1995a; Franqueza et al., 1997).
At pHo 6.5 and 7.4, R(+)bupivacaine induced an
instantaneous block at t=0 ms that was not observed at
pHo 10.0. This initial block, which appears before channel
opening could be attributed to the drug interaction with a
non conducting state of the channel. Consistent with this
hypothesis, at pHo 6.5 and 7.4, R(+)bupivacaine accelerated
the activation time constant at +60 mV vs that recorded in
the absence of the drug in the same conditions.
As it can be observed in Figures 1, 3 and 6, acidification of
the pHo produced a 4 fold decrease in the potency of
R(+)bupivacaine to block hKv1.5 channels when compared
to data obtained at pHo 7.4. This lower potency could be
attributed to a slower association time constant (k) for
R(+)bupivacaine (the k value at pHo 7.4 was 3.7 times faster
than at pHo 6.5), since the dissociation time constants (l) at
the two pHo were similar. However, at pHo 10.0 the potency
of R(+)bupivacaine to block hKv1.5 channels was 2.5 fold
times higher than that described at pHo 7.4. This higher
potency could be explained by the acceleration observed in
the k value (9.1 fold times faster than that calculated at pHo
7.4) together with a 2.8 fold times faster l value.
Similarly to that reported for R(+)bupivacaine in blocking
the flicker K+ channel present in thin myelinated nerve fibres
and in hKv1.5 mutated channels (T505I, T505S and T477S),
at pHo 6.5 and 10.0, concentration-dependent block of
hKv1.5 channels by R(+)bupivacaine best fits have been
obtained under the assumption of two independent binding
processes (Franqueza et al., 1997; Nau et al., 1999). These
findings could be explained on the basis of the existence of
two dierent populations of channels with dierent R(+)bu-
pivacaine anity. However, this seems unlikely to occur with
a cloned channel that forms homomultimers. Heteromultimer
formation with endogenous subunits is also unlikely, since
the Ltk7 cells used do not contain endogenous voltage gated
ion currents or detectable K+ channel mRNA (Snyders et al.,
1993). A second possible explanation is that changes observed
in channel gating observed in mutant channels or following
changes in pHo may introduce a high-anity binding site for
bupivacaine in hKv1.5 channels. However, if this would be
the case, then all the current would be inhibited by the high-
anity binding site before the low-anity site could be
occupied, thus masking low-anity binding. The hypothesis
we favour is that even in wild type hKv1.5 channels multiple
Figure 7 Time-dependent block of hKv1.5 channels induced by R(+)bupivacaine at dierent pHo values observed during
deactivation at 740 mV (at pHo 7.4 and 10.0) and 730 mV (at pHo 6.5). R(+)bupivacaine induced an initial rising phase due to
the unblocking of R(+)bupivacaine from open channels and slowed the deactivation time course at all the pHo studied which
resulted in a crossover phenomenon indicative of an open-channel block mechanism. The arrows indicate the ‘crossover’ between
the tail currents recorded in the presence of drug and those recorded under control conditions.
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open states exist with dierent bupivacaine anities.
Bupivacaine binding to the high-anity open state could
represent an intermediate transition state in wild type hKv1.5
channels under physiological conditions (pHo=7.4), as has
been proposed previously to explain the blockade of cardiac
Na+ channels by QX-314 (Gingrich et al., 1993). Under this
framework, hKv1.5 channels with a modified gating induced
by changes in pHo would be stabilizing an ultrafast (higher
anity) interaction between bupivacaine and hKv1.5 chan-
nels. In fact, there is evidence that multiple open states exist
in hKv1.5 channels and that conversion between them can be
influenced by drug concentration (Rich, 1996). Thus, as
bupivacaine concentration increases, an open state with low
anity is favoured. This hypothesis requires a drug-induced
shift in gating that is independent of open-channel block,
such as that observed at pHo 6.5. Thus, at pHo 6.5 and 10.0,
conformational changes induced by a higher or a lower
proton concentration would promote a drug-induced shift in
channel gating that reveal an open state with lower anity
for bupivacaine. However, the mechanism responsible for the
biphasic dose-response curves requires further investigation.
Possible contribution of R(+)bupivacaine-binding to
the external binding site to the total block induced on
hKv1.5 channels
It has been generally accepted that the blocking eects of
R(+)bupivacaine were mostly due to the interaction between
the intracellular cationic form of the drug with the inner
mouth of the ion pore (Valenzuela et al., 1995a; Franqueza et
al., 1997). If this hypothesis is correct, we would expect to
find KD values at dierent pHo that correspond to similar
intracellular cationic concentration of R(+)bupivacaine
([RB+]in). However, as it can be observed in Table 1, at the
three KD values obtained in this study, the theoretical [RB
+]in
were dierent. In fact, if we consider only the [RB+]in at the
KD value calculated at each pHo studied, the concentration
required to induce a similar degree of block increases as the
pHo is more alkaline, indicating that R(+)bupivacaine
potency decreases as the pHo increases. At the three pHo
tested, the concentrations of RB+ at the external side of the
membrane ([RB+]out) are very dierent. Recently, we have
demonstrated the existence of an external binding site for
R(+)bupivacaine in hKv1.5 channels (Longobardo et al.,
2000). Therefore, these results may suggest that the relative
contribution of R(+)bupivacaine-binding to the external
receptor site to the total block observed is prominent at
pHo 6.5, less important at pHo 7.4 and almost negligible at
pHo 10.0. As mentioned above, it has been described that at
pH 6.2, the protonation of a histidine at position 452 of
Kv1.5 channels, induces the channels to accumulate in the
inactivated state (Steidl & Yool, 1999). In addition, we have
described that binding of a permanently charged bupivacaine
analog to the internal bupivacaine receptor site modifies the
eects induced by the permanently charged analogue
extracellularly applied (RB+1Cout) when the experimental
conditions promote the inactivated state of the channel (long
depolarizing pulses) (Longobardo et al., 2000). In fact, the
degree of block induced by RB+1Cout was higher in the
presence of RB+1C at the internal side of the membrane at
the end of a 4 s depolarizing pulse than in the absence of
drug in the intracellular media. Therefore, a possible
explanation for the observed increased block at lower [RB+]in
(observed at pHo 6.5) could be the functional coupling
between both receptor sites.
Agonist effects of R(+)bupivacaine at pHo 6.5
During the application of 250 ms depolarizing pulses from
780 mV to +60 mV, R(+)bupivacaine blocked hKv1.5
channels at the three pHo studied. However, at membrane
potentials close to the threshold for channel activation,
R(+)bupivacaine eects were dierent depending on the pHo
value. At low pHo, at which the concentration of the
extracellular cationic form of the drug is much higher, we
observed an agonist eect at negative potentials (710 mV)
that was not observed neither at pHo 7.4 nor at pHo 10.0.
This eect was likely due to the drug-induced shift of the
activation curve to more negative potentials, as it has been
described for other potassium channels and drugs (Carmeliet,
1993; Tseng et al., 1996; Davies et al., 1996; Delpo´n et al.,
1999). At pHo 6.5, drug is mostly present in its cationic form
at the external side of the membrane, which may suggest that
it is the charged form of bupivacaine the one which exherts
the ‘agonist eect’ by binding to the receptor site located at
the external side of the membrane. On the other hand,
bupivacaine is a very hydrophobic drug with a lipid phase/
aqueous phase partition coecient (logP) of 4.0. Given its
pKa value (8.1), the lipid/buer distribution coecient (logQ)
is 2.4, 3.2 and 4.0 at pHo 6.5, 7.4 and 10.0, respectively.
These values predict that drug concentration at the cell
membrane will increase 240, 320 and 400 fold at pHo 6.5, 7.4
and 10.0, respectively. Thus, at the KD values calculated for
these pHo values, the theoretical expected drug concentration
at the cell membrane will be 4560, 1504 and 6783 mM,
respectively. Therefore, we cannot rule out the possibility that
the uncharged form of the drug would be responsible of the
observed shift in the activation curve. In fact, it has been
described that neutral local anaesthetics, such as benzocaine,
induce, at low concentrations, similar eects on these
potassium channels (Delpo´n et al., 1999)
Possible clinical consequences of the present study
It has been described that bupivacaine cardiotoxicity
increases in acidosis and hypoxia (Rosen et al., 1985;
Nancarrow et al., 1987). During acidosis, most ionic currents,
including hKv1.5, INa, ICa, ITO, IKr and IKs, are inhibited by
extracellular protons (Prod’hom et al., 1989; Zhang &
Siegelbaum, 1991; Yamane et al., 1993; Stengl et al., 1998;
Anumonwo et al., 1999; Steidl & Yool, 1999). These eects
on ion channels are translated, at the multicellular level, into
a depolarization of the membrane potential, a reduction of
conduction velocity, and a prolongation of the action
potential duration, with eventual oscillations at the plateau
level and occurrence of early afterdepolarizations (Coraboeuf
et al., 1980; Cordeiro et al., 1994). Bupivacaine not only
blocks hKv1.5 channels, but also those responsible of the
activation of IKr, IKs and ITO (Castle, 1990; Lipka et al., 1998;
Franqueza et al., 1999; Gonza´lez et al., 2001). Therefore, a
further decrease of hKv1.5 current, would be expected to be
accompanied by a prolongation of the atrial action potential,
which could be, together with its eects on other K+
currents, responsible of the higher bupivacaine cardiotoxicity.
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However, the increased bupivacaine cardiotoxicity at low
pHo would also involve its blocking eects on cardiac Na
+
channels. In fact, under these conditions, the resting
membrane potential is depolarized to levels which promote
the transition of Na+ channels from the rested to the
inactivated state, which makes them more susceptible to be
blocked by bupivacaine (Clarkson & Hondeghem, 1985;
Valenzuela et al., 1995b), and, as a consequence, the
conduction velocity will decrease to a higher extent,
contributing to the observed higher cardiotoxicity.
Conclusions
In this study, we demonstrated that R(+)bupivacaine
potency to block hKv1.5 channels increases in parallel with
the increase in the pHo and, thus, with the increase in the
intracellular concentration of the cationic form of the drug.
Also, at low pHo (6.5), R(+)bupivacaine increases hKv1.5
current at negative membrane potentials, likely due to the
drug induced shift of the activation curve. At the KD values,
intracellular concentrations of the cationic form of R(+)bu-
pivacaine do not match at the dierent pHo, suggesting that
either: (a) binding to the extracellular bupivacaine binding
site, or (b) the influence of hKv1.5 channel inactivation, that
predominates at low pHo, might determine the blocking
eects of R(+)bupivacaine on hKv1.5 channels.
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